Xie H - Search Results

1

Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4.

Ye C, Zhang X, Chen X, Cao Q, Zhang X, Zhou Y, Li W, Hong L, Xie H, Liu X, Cao H, Wang YJ, Kang B. Ye C, et al. Among authors: xie h. Cell Oncol (Dordr). 2020 Apr;43(2):279-295. doi: 10.1007/s13402-019-00487-3. Epub 2019 Dec 17. Cell Oncol (Dordr). 2020. PMID: 31848930

2

MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.

Wu LM, Zhang F, Xie HY, Xu X, Chen QX, Yin SY, Liu XC, Zhou L, Xu XB, Sun YL, Zheng SS. Wu LM, et al. Among authors: xie hy. Clin Genet. 2008 Mar;73(3):273-8. doi: 10.1111/j.1399-0004.2007.00955.x. Epub 2008 Jan 3. Clin Genet. 2008. PMID: 18177474

3

[Expression and prognostic value of Polo-like kinase 1, E-cadherin in the patients with hepatocellular carcinoma].

Chen XJ, Wu LM, Xu XB, Feng XW, Xie HY, Zhang M, Shen Y, Wang WL, Liang TB, Zheng SS. Chen XJ, et al. Zhonghua Wai Ke Za Zhi. 2007 Oct 1;45(19):1354-8. Zhonghua Wai Ke Za Zhi. 2007. PMID: 18241575 Chinese.

4

Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.

Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, Zheng SS. Zhang F, et al. Ann Surg Oncol. 2008 Dec;15(12):3494-502. doi: 10.1245/s10434-008-0146-1. Epub 2008 Oct 2. Ann Surg Oncol. 2008. PMID: 18830757

5

HSG provides antitumor efficacy on hepatocellular carcinoma both in vitro and in vivo.

Wang W, Zhu F, Wang S, Wei J, Jia C, Zhang Y, Zhou L, Xie H, Zheng S. Wang W, et al. Among authors: xie h. Oncol Rep. 2010 Jul;24(1):183-8. Oncol Rep. 2010. PMID: 20514460

6

Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation.

Wu LM, Zhang F, Zhou L, Yang Z, Xie HY, Zheng SS. Wu LM, et al. BMC Cancer. 2010 Aug 2;10:399. doi: 10.1186/1471-2407-10-399. BMC Cancer. 2010. PMID: 20678188 Free PMC article.

7

Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma.

Wu LM, Yang Z, Zhou L, Zhang F, Xie HY, Feng XW, Wu J, Zheng SS. Wu LM, et al. PLoS One. 2010 Dec 29;5(12):e14460. doi: 10.1371/journal.pone.0014460. PLoS One. 2010. Retraction in: PLoS One. 2019 Jul 31;14(7):e0220822. doi: 10.1371/journal.pone.0220822 PMID: 21206745 Free PMC article. Retracted.

8

Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.

Zhang W, Zhou L, Ding SM, Xie HY, Xu X, Wu J, Chen QX, Zhang F, Wei BJ, Eldin AT, Zheng SS. Zhang W, et al. Oncol Rep. 2011 Apr;25(4):1053-62. doi: 10.3892/or.2011.1159. Epub 2011 Jan 24. Oncol Rep. 2011. PMID: 21271221

9

Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection.

Chen KJ, Zhou L, Xie HY, Ahmed TE, Feng XW, Zheng SS. Chen KJ, et al. Med Oncol. 2012 Sep;29(3):1817-26. doi: 10.1007/s12032-011-0006-x. Epub 2011 Jun 16. Med Oncol. 2012. PMID: 21678026

10

NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.

Cheng J, Xie HY, Xu X, Wu J, Wei X, Su R, Zhang W, Lv Z, Zheng S, Zhou L. Cheng J, et al. Cancer Lett. 2011 Nov 1;310(1):35-45. doi: 10.1016/j.canlet.2011.06.001. Epub 2011 Jun 24. Cancer Lett. 2011. PMID: 21763068

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,372 results

Search Page

Filters